Tiziana Life Sciences Ltd. (TLSA): Qarzning balans kapitallashuviga nisbati
Tiziana Life Sciences (TLSA) raqobatchilarni chetlab o'tish uchun burun orqali yuborish usulidan foydalangan holda, yallig'lanishga qarshi kurashish uchun noyob antitanalarni yaratadi. Biznesning muvaffaqiyati klinik sinovlar natijalari, patent himoyasi va investitsiyalar oqimiga bog'liq bo'lib, joriy ko'rsatkich 0.00 darajasida turibdi. Ushbu narxlar grafigi neyrodegenerativ patologiyalar uchun dori vositalarini ishlab chiqish orqali inhalatsiya terapiyasi segmentini egallash strategiyasiga tegishli ma'lumotlarni to'ldiradi.
&width=1200&height=400&colorIndex=0&v=mvujvhid.si-7ayy9s0&start=20220704&end=20261030&filename=GURU_Markets_-_TLSA_-_Tiziana-Life-Sciences_-_Debt-to-Net-Assets-Ratio "TLSA: Tiziana Life Sciences Qarzning balans kapitallashuviga nisbati 04.07.2022 - 30.10.2026 | 👁️GURU.Markets👁️")
Tiziana Life Sciences Ltd. (TLSA) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil
- joriy narx va aksiyalarning prognoz qilingan qiymati:
- birja kapitallashuvi ma'lumotlari:
- xususiy kapitalning balans qiymati ko'rsatkichlari:
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Umumiy qarzning xususiy kapitalga nisbati Tiziana Life Sciences|TLSA - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Qisqa muddatli qarzning kapitalga nisbati Tiziana Life Sciences PLC|TLSA - Kompaniyaning umumiy qarz majburiyatlari|Qarzning balans kapitallashuviga nisbati Tiziana Life Sciences, Ltd.|TLSA - Kompaniyaning uzoq muddatli majburiyatlari|Kompaniyaning qisqa muddatli qarzi Tiziana Life Sciences|Tezkor likvidlik ko‘rsatkichi tizianalifesciences.com
- biznes foydasi va investitsiya koeffitsiyentlari ma'lumotlari:
Kompaniyaning har tomonlama tahlili:TLSA (Tiziana Life Sciences)
Tiziana Life Sciences kompaniyasining inhalatsion immunoterapiya segmentiga kengayishi monoklonal antitelalarning ishlab chiqilishini kengaytirish uchun katta miqdorda moliyalashtirishni talab qiladi. Firma balansining kapitalizatsiyasidagi qarz mablag'larining ulushini tahlil qilib, investor qarzdorlikning kapitalga nisbati ko'rsatkichini baholaydi: ushbu ko'rsatkichning pasayish tendentsiyasi bankrotlik xavfini minimallashtiradi, biroq haddan tashqari konservativlik biznes o'sish sur'atlarining to'xtab qolganligidan dalolat berishi mumkin.
Tiziana Life Sciences (TLSA) raqobatchilari
Balans kapitallashuviga qarzlar ARGX (argenx SE)|Balans kapitallashuviga qarzlar biontech.de BNTX|ABVX - Qarzning balans kapitallashuviga nisbati|Qarzning sof aktivlarga nisbati ADMA (ADMA Biologics Inc)|Protagonist Therapeutics Inc (PTGX) - Qarzning balans kapitallashuviga nisbati|Qarzning balans qiymatiga nisbati Immunovant Therapeutics|KNSA (Kiniksa Pharmaceuticals) - Balans kapitallashuviga qarzlar|Balans kapitallashuviga qarzlar grifols.com|Qarzning balans qiymatiga nisbati ADPT (Adaptive Biotechnologies Corporation)|CLDX (Celldex Therapeutics Inc) - Qarzning sof aktivlarga nisbati|Balans kapitallashuviga qarzlar AUPH (Aurinia Pharma)|Sof aktivlarga qarzlar BioCryst Corp (BCRX)|VERA - Qarzning balans kapitallashuviga nisbati|dianthustx.com (DNTH) - Qarzning balans qiymatiga nisbati|Pharvaris (PHVS) - Qarzning balans kapitallashuviga nisbati|Qarzning balans qiymatiga nisbati AbCellera Bio|Qarzning balans qiymatiga nisbati TRML|Balans kapitallashuviga qarzlar Precigen Corp|Qarzning balans kapitallashuviga nisbati Pharming Group N.V. (PHAR)|nektar.com - Qarzning balans qiymatiga nisbati|Balans kapitallashuviga qarzlar UPB (Upstream Bio)|Zenas Bio (ZBIO) - Balans qiymatiga qarzlar|IMNM: Qarzning balans qiymatiga nisbati|Gossamer Bio Corp. - Qarzning balans kapitaliga nisbati|KALV: Balans kapitallashuviga qarzlar|SEPN - Sof aktivlarga qarzlar|Qarzning balans qiymatiga nisbati PVLA|Savara Inc - Qarzlarning balans kapitallashuviga nisbati|Balans kapitallashuviga qarzlar RIGL|Sof aktivlarga qarzlar AnaptysBio Inc.|Balans kapitallashuviga qarzlar ATXS (Astria Therapeutics)|Balans kapitallashuviga qarzlar engene.com ENGN|RAPT - Qarzning balans kapitallashuviga nisbati|JBIO (Aerovate Therapeutics Inc) - Qarzning balans qiymatiga nisbati|ACRS: Balans kapitallashuviga qarzlar|Kyverna Therapeutics, Inc (KYTX) - Balans kapitallashuviga qarzlar|Qarzning balans qiymatiga nisbati CABA|VTYX: Qarzning sof aktivlarga nisbati|Qarzning balans kapitallashuviga nisbati Theratechnologies (THTX)|Qarzning balans kapitallashuviga nisbati AVTX (Avalo Therapeutics, Inc.)|Balans kapitallashuviga qarzlar ELDN (Eledon)|Sof aktivlarga qarzlar Agenus, Inc (AGEN)|Climb Bio Inc - Balans kapitallashuviga qarzlar|Qarzlarning balans kapitallashuviga nisbati ZURA|ATYR: Balans kapitallashuviga qarzlar|Balans qiymatiga qarzlar Adagene Inc. (ADAG)|Qarzning balans qiymatiga nisbati IMA|STTK: Qarzning sof aktivlarga nisbati|Qarzning balans kapitallashuviga nisbati Equillium, Inc. (EQ)|Sof aktivlarga qarzlar connectbiopharm.com|Balans kapitallashuviga qarzlar IMUX (Immunic)|ATRA - Qarzning balans qiymatiga nisbati|InflaRx GmbH - Balans kapitallashuviga qarzlar|Sof aktivlarga qarzlar X4 Pharmaceuticals, Inc XFOR|ACET: Balans kapitallashuviga qarzlar|Balans qiymatiga qarzlar Celularity (CELU)|Qarzning balans kapitallashuviga nisbati INmune Bio|Qarzning balans qiymatiga nisbati BRNS (Barinthus Biotherapeutics PLC)|Balans kapitallashuviga qarzlar KZR|Qarzning balans qiymatiga nisbati SAB Biotherapeutics Inc SABS|Balans kapitallashuviga qarzlar AKTX (Akari Therapeutics)|Enlivex Therapeutics Ltd (ENLV) - Balans qiymatiga qarzlar|QTTB - Qarzning balans kapitallashuviga nisbati|Sof aktivlarga qarzlar GeoVax Labs GOVX|EDSA (Edesa) - Qarzning balans qiymatiga nisbati|IBIO: Qarzning balans kapitaliga nisbati|Qarzning balans kapitallashuviga nisbati Carisma Therapeutics Inc|Qarzning balans kapitallashuviga nisbati XTLB|Qarzning balans kapitallashuviga nisbati Bolt Biotherapeutics (BOLT)|Sof aktivlarga qarzlar hcwbiologics.com|Balans kapitallashuviga qarzlar APVO (Aptevo Therapeutics Inc.)|Balans kapitallashuviga qarzlar AIM ImmunoTech, Inc. AIM|ADTX - Qarzning balans kapitallashuviga nisbati|Qarzlarning balans kapitallashuviga nisbati GRI|XRTX: Balans kapitallashuviga qarzlar|Vyome Holdings Inc. - Qarzning sof aktivlarga nisbati|REVB (Revelation Bio) - Balans kapitallashuviga qarzlar|Balans kapitallashuviga qarzlar Indaptus Corp|Qarzning balans kapitallashuviga nisbati Scinai Immunotherapeutics (SCNI)|CALI (calcimedica.com) - Qarzning sof aktivlarga nisbati|Qarzning balans kapitallashuviga nisbati Affimed N.V. AFMD|ALLK - Qarzning balans qiymatiga nisbati|HOOKIPA - Balans kapitallashuviga qarzlar|IGMS - Balans kapitallashuviga qarzlar|ITOS (iTeos Therapeutics) - Qarzning balans qiymatiga nisbati|oceanbiomedical.com - Qarzning sof aktivlarga nisbati|TCBP (TC BioPharm) - Balans kapitallashuviga qarzlar|Third Harmonic Bio Inc. (THRD) - Sof aktivlarga qarzlar